China is in the midst of conducting a series of corruption investigations of pharmaceutical companies that have been operating in the country. It all started with the investigation of officials from pharmaceutical…
Academic rigour, journalistic flair
Articles on Big Pharma
Displaying 61 - 80 of 82 articles
In 2001 I met David Graham, an official from the US Food and Drug Administration, in a car park in Washington. I wanted him to shed light on why the diabetes drug troglitazone, or Rezulin, had been available…
A study published today shows that clinical trials with industry sponsorship report greater benefits and fewer harmful side effects. In the discussion, the authors note that most reviews and guidelines…
You’ve probably given little thought to the slip of paper your GP hands you when she sends you off for a blood test. After all, you’re likely to have more important things to worry about. But the next…
The earthquake in the Northern Italian town of Medolla this May devastated the local community, killing 17 people and leaving 14,000 homeless. Because Medolla is the manufacturing epicentre of the Italian…
New medicines must be approved as safe, efficacious and of good quality before they can be prescribed. But authors of two recent articles in the British Medical Journal argue that governments should introduce…
If it involved the record industry we’d call it payola: undisclosed kickbacks to radio station executives, owners and disk jockeys to boost broadcasts and thus record sales. In the pharmaceutical industry…
Pharmaceutical companies will be required to disclose more details about their financial ties to doctors under a revised…
Two large multinational pharmaceutical companies are fighting for patents and monopoly pricing in Indian courts. The outcomes of the cases – involving Novartis and Bayer – are likely to determine the country’s…
Anti-cholesterol drug Lipitor® (atorvastatin) has been estimated to generate Pfizer revenues of more than $130bn worldwide. Australian taxpayers’ share of this is about $7bn, through subsidies from the…
TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
How would you feel if your local GP or specialist was pocketing money from a drug company to promote its products? If your gut tells you that this falls squarely into the category of Very Bad Ideas then…
The 2008 global financial crisis and an impending “patent cliff” have had a profound impact on the profitability of the pharmaceutical industry – they have made it change how it works. So, to maintain…
Many pharmaceutical companies are having to re-examine their product portfolio because of the difficult economic climate. New uses for established drugs affords a way for these companies to maximise financial…
It’s the pharmaceutical industry equivalent of the butterfly effect: a drug manufacturing plant in Ohio shuts down production after regulators on two continents uncover contamination problems. Suddenly…
The enormous medical impact of modern pharmaceuticals has on occasion been matched by some large-scale litigation regarding adverse events. The Vioxx litigation in Australia and elsewhere is one such recent…
First it was the Pharmacy Guild’s deal with Blackmores that raised ethical concerns. Now it’s the Guild and Pfizer. Both deals involve undisclosed payments from drug companies to Guild subsidiaries to…
Welcome to “The most powerful companies you’ve never heard of” – an ongoing series from The Conversation that sheds light on big companies with low profiles. Today, Deakin University’s Philip Soos examines…
This week Radio National’s Background Briefing looks at how pharmaceutical companies market their products to doctors. The program is presented by Ray Moynihan, an award-winning journalist, columnist at…
“Would you like the generic brand of that medicine?” It’s a question you’ve probably been asked, or at least heard, when picking up a prescription at your local pharmacy. It’s likely you were told the…
Job Board
-
Research Fellow
-
Senior Lecturer in Nursing
-
DIGITAL PRODUCT OWNER
-
Senior Lecturer in Management
-
Head of Patient Programs
Top contributors
-
Professor Emeritus of Health Policy and Management, York University, Emergency Physician at University Health Network, Associate Professor of Family and Community Medicine, University of Toronto
-
Assistant Professor, Bond University
-
Senior Research Fellow, Bioethics, University of Sydney
-
Assistant Professor, School of Law, University of Canberra
-
Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney
-
Ken Harvey is a Friend of The Conversation.
Associate Professor, School of Public Health and Preventive Medicine, Monash University
-
Associate Professor Politics and Policy Studies, Deakin University
-
Postdoctoral Researcher, Sydney Health Ethics, University of Sydney
-
Lecturer in Accounting & Management, Lancaster University
-
Chair professor, University of Sydney
-
Brett Montgomery is a Friend of The Conversation.
Senior Lecturer in General Practice, University of Western Australia
-
Adjunct Professor, Murdoch University
-
Dean, University of Wollongong
-
Professor; Head, School of Clinical Sciences, Queensland University of Technology
-
Research Leader, Critical and Ethical Mental Health research group, Robinson Research Institute, University of Adelaide
